beta

VBIV

VBI Vaccines, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, the Sci-B-Vac and VBI-2601. It also develops enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

Market Cap: 457 Million

Primary Exchange: NASDAQ

Website: http://www.vbivaccines.com

Shares Outstanding: 231 Million

Float: 205 Million

Dividend: (%)

Beta: 0.946340015277367

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1803 trading days

From: 2013-07-31 To: 2020-05-28

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2014-07-29 5.0 1.0 5.0
Data provided by IEX Cloud